Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacotherapy: Biosimilar switching

× No keyword cloud information.

5 in total

1. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.

Authors: Kristin K Jørgensen; Inge C Olsen; Guro L Goll; Merete Lorentzen; Nils Bolstad; Espen A Haavardsholm; Knut E A Lundin; Cato Mørk; Jørgen Jahnsen; Tore K Kvien
Journal: Lancet Date: 2017-05-11 Impact factor: 79.321

2. The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis.

Authors: C E M Griffiths; D Thaçi; S Gerdes; P Arenberger; G Pulka; K Kingo; J Weglowska; N Hattebuhr; J Poetzl; H Woehling; G Wuerth; M Afonso
Journal: Br J Dermatol Date: 2017-03-01 Impact factor: 9.302

3. Letter--Draft FDA Guidance "Considerations in Demonstrating Interchangeability with a Reference Product": Overview and Presentation-Related Concerns.

Authors: Elan Rubinstein
Journal: J Manag Care Spec Pharm Date: 2017-03

4. Clinical trials of biosimilars should become more similar.

Authors: Jonathan Kay; John D Isaacs
Journal: Ann Rheum Dis Date: 2016-08-25 Impact factor: 19.103

5. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.

Authors: Dae Hyun Yoo; Pawel Hrycaj; Pedro Miranda; Edgar Ramiterre; Mariusz Piotrowski; Sergii Shevchuk; Volodymyr Kovalenko; Nenad Prodanovic; Mauricio Abello-Banfi; Sergio Gutierrez-Ureña; Luis Morales-Olazabal; Michael Tee; Renato Jimenez; Omid Zamani; Sang Joon Lee; HoUng Kim; Won Park; Ulf Müller-Ladner
Journal: Ann Rheum Dis Date: 2013-05-16 Impact factor: 19.103